We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHDX
2051
DELISTED
Genomic Health, Inc.
GHDX
$21K ﹤0.01%
615
-2,379
-79% -$75.9K
PAY
2052
DELISTED
Verifone Systems Inc
PAY
$21K ﹤0.01%
1,175
-10,297
-90% -$191K
IMDZ
2053
DELISTED
Immune Design Corp.
IMDZ
$21K ﹤0.01%
5,333
+3,108
+140% +$16.9K
AGX icon
2054
Argan
AGX
$8.37B
$20K ﹤0.01%
433
-826
-66% -$49.2K
CEF icon
2055
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$20K ﹤0.01%
1,200
+900
+300% +$11.8K
CRD.B icon
2056
Crawford & Co Class B
CRD.B
$604M
$20K ﹤0.01%
2,097
+256
+14% +$2.71K
CVGI icon
2057
Commercial Vehicle Group
CVGI
$147M
$20K ﹤0.01%
1,871
-21,309
-92% -$205K
CXW icon
2058
CoreCivic
CXW
$3.19B
$20K ﹤0.01%
873
+23
+3% +$553
DVAX
2059
DELISTED
Dynavax Technologies
DVAX
$20K ﹤0.01%
1,049
-2,138
-67% -$42.9K
ECVT icon
2060
Ecovyst
ECVT
$1.14B
$20K ﹤0.01%
+1,200
New +$19.7K
ESPR
2061
DELISTED
Esperion Therapeutics
ESPR
$20K ﹤0.01%
+306
New +$16.5K
EVR icon
2062
Evercore
EVR
$11.8B
$20K ﹤0.01%
219
-5,001
-96% -$417K
FC icon
2063
Franklin Covey
FC
$246M
$20K ﹤0.01%
981
-284
-22% -$5.57K
FMBH icon
2064
First Mid Bancshares
FMBH
$1.36B
$20K ﹤0.01%
530
+335
+172% +$13.1K
GPK icon
2065
Graphic Packaging
GPK
$3.58B
$20K ﹤0.01%
1,297
-7,154
-85% -$108K
IDCC icon
2066
InterDigital
IDCC
$8.89B
$20K ﹤0.01%
263
-4,326
-94% -$323K
KNX icon
2067
Knight Transportation
KNX
$11.4B
$20K ﹤0.01%
452
-6,940
-94% -$285K
LGND icon
2068
Ligand Pharmaceuticals
LGND
$6.36B
$20K ﹤0.01%
231
-2,085
-90% -$181K
MPX
2069
DELISTED
Marine Products Corp
MPX
$20K ﹤0.01%
1,521
+870
+134% +$12.9K
NWG icon
2070
NatWest
NWG
$76.4B
$20K ﹤0.01%
2,485
+1,092
+78% +$8.73K
OEC icon
2071
Orion
OEC
$409M
$20K ﹤0.01%
795
+45
+6% +$1.06K
ORGO icon
2072
Organogenesis Holdings
ORGO
$239M
$20K ﹤0.01%
2,028
+852
+72% +$8.46K
PCYO icon
2073
Pure Cycle
PCYO
$261M
$20K ﹤0.01%
2,425
+1,128
+87% +$8.49K
PHG icon
2074
Philips
PHG
$26.1B
$20K ﹤0.01%
684
-3,588
-84% -$108K
SHYF
2075
DELISTED
The Shyft Group
SHYF
$20K ﹤0.01%
1,306
-6,077
-82% -$92.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.